GAL-1A Plus Blood Glucose Monitoring System
K-Number: K213887 · 2022-03-29
Device Summary
Frequently Asked Questions
What is the GAL-1A Plus Blood Glucose Monitoring System?
GAL-1A Plus Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-03-29. It is manufactured by Apex BioTechnology Corp.. The 510(k) number is K213887.
When was GAL-1A Plus Blood Glucose Monitoring System approved by the FDA?
GAL-1A Plus Blood Glucose Monitoring System received FDA 510(k) clearance on 2022-03-29, under approval number K213887.
What company makes GAL-1A Plus Blood Glucose Monitoring System?
GAL-1A Plus Blood Glucose Monitoring System is manufactured by Apex BioTechnology Corp..
What is the FDA product code for GAL-1A Plus Blood Glucose Monitoring System?
The FDA product code for GAL-1A Plus Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
Related Clinical Trials
Related PubMed Literature
Other Devices by Apex BioTechnology Corp.
Related Devices (Code: NBW)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.